Search
for
Sort by
Research 121–150 of 1000+
- Increased CRHR1 expression on monocytes from patients with AA enables a pro‐inflammatory response to corticotrophin‐releasing hormone
- Does the corticotropin-releasing hormone system play a role in the pathogenesis of lichen planus?
- A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome
- Human scalp hair: Modulation by various factors and hormones do estrogens inhibit or stimulate—A perplexing perspective
- Vitamin D: More Than a “Bone-a-Fide” Hormone
- Age‐dependent regulation by androgens of gene expression in the anterior hypothalamus and stress‐induced release of adrenal hormones in adolescent and adult male rats
- Beyond acne: Current aspects of sebaceous gland biology and function
- Oestrogen functions in skin and skin appendages
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- “Sebocytes’ makeup” - Novel mechanisms and concepts in the physiology of the human sebaceous glands
- Estrogens and Human Scalp Hair Growth—Still More Questions than Answers
- Gender Differences in Cardiac Hypertrophy
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Androgens trigger different growth responses in genetically identical human hair follicles in organ culture that reflect their epigenetic diversity in life
- Aromatase inhibitors induce ‘male pattern hair loss’ in women?
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Expansion of specialized epidermis induced by hormonal state and mechanical strain
- Bladder Cancer: The Hormonal Dependence Enigma and a New Hormonal Player
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Outcome and clinical–biological characteristics of patients with advanced breast cancer undergoing removal of ovarian/pelvic metastases
- Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives
- Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis
- Sexually dimorphic sail feathers in the Mandarin duck as a model for lifelong developmental modulation
- An adolescent girl presenting with primary amenorrhea: A case report of complete androgen insensitivity syndrome
- Cell-free fat extract restores hair loss: a novel therapeutic strategy for androgenetic alopecia
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”